Kenison Michael R.'s Form 4 filing
Proto Labs Inc (PRLB) · filed Nov 26, 2025
- Accession no.
- 0001870293-25-000004
- Filed
- Nov 26, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $152.9K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001870293-25-000007 (Dec 3, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kenison Michael R.CIK 0001870293 | Officer (Chief Operations Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +3,048 | $33.84 | +$103,144.32 | 31,946 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −3,048 | $50.17F3 | −$152,918.16 | 28,898 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −3,048 | $0.00 | $0 | 4,664 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects the weighted average price of 3,048 shares of Common Stock of the issuer sold by the Reporting Person in multiple transactions on November 25, 2025 with sale prices ranging from $50.00 to $50.53 per share. The Reporting Person undertakes to provide upon request by U.S. Securities and Exchange Commission staff, the issuer, or a securityholder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.